PROLOR BIOTECH, INC.: 10-K/A filed 2012-03-23

Name: PROLOR BIOTECH, INC.: 10-K/A filed 2012-03-23
Creator: PROLOR BIOTECH, INC.

What PROLOR BIOTECH, INC. reported in its annual report amendment filed 2012-03-23 (fiscal FY 2011): 19 published measures, 68 facts as tagged in accession 0001144204-12-016915.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form: 10-K/A (annual report amendment)
Filed: 2012-03-23
Fiscal period: fiscal FY 2011
Accession: 0001144204-12-016915 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PROLOR BIOTECH, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2011-12-31	15,024,571	USD
At 2010-12-31	26,813,109	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2011-12-31	12,521,282	USD
At 2010-12-31	24,994,559	USD
At 2009-12-31	3,129,065	USD
At 2008-12-31	7,867,862	USD
At 2007-12-31	11,862,370	USD
At 2006-12-31	548,765	USD
At 2005-12-31	2,154,675	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2011-12-31	13,261,687	USD
At 2010-12-31	24,082,566	USD
At 2009-12-31	3,457,402	USD
At 2008-12-31	7,436,054	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2011-01-01 to 2011-12-31	-15,063,055	USD	365
2005-06-01 to 2011-12-31	-49,647,011	USD	2405
2010-01-01 to 2010-12-31	-7,559,131	USD	365
2009-01-01 to 2009-12-31	-7,484,718	USD	365
2008-01-01 to 2008-12-31	-7,033,536	USD	366
2007-01-01 to 2007-12-31	-3,313,203	USD	365
2006-01-01 to 2006-12-31	-2,215,949	USD	365
2005-06-01 to 2005-12-31	-6,977,419	USD	214

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2011-01-01 to 2011-12-31	-11,969,986	USD	365
2005-06-01 to 2011-12-31	-33,920,728	USD	2405
2010-01-01 to 2010-12-31	-6,243,222	USD	365
2009-01-01 to 2009-12-31	-5,892,390	USD	365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2011-01-01 to 2011-12-31	721,997	USD	365
2005-06-01 to 2011-12-31	1,343,827	USD	2405
2010-01-01 to 2010-12-31	152,929	USD	365
2009-01-01 to 2009-12-31	52,651	USD	365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2011-01-01 to 2011-12-31	668,852	USD	365
2005-06-01 to 2011-12-31	49,536,650	USD	2405
2010-01-01 to 2010-12-31	28,541,200	USD	365
2009-01-01 to 2009-12-31	2,017,580	USD	365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2011-01-01 to 2011-12-31	480,255	USD	365
2005-06-01 to 2011-12-31	-2,354,235	USD	2405
2010-01-01 to 2010-12-31	-1,672,814	USD	365
2009-01-01 to 2009-12-31	-103,842	USD	365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2011-12-31	898,254	USD
At 2010-12-31	350,284	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2011-01-01 to 2011-12-31	1,920,926	USD	365
2005-06-01 to 2011-12-31	10,000,136	USD	2405
2010-01-01 to 2010-12-31	883,425	USD	365
2009-01-01 to 2009-12-31	728,341	USD	365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2011-01-01 to 2011-12-31	-14,847,327	USD	365
2005-06-01 to 2011-12-31	-50,067,268	USD	2405
2010-01-01 to 2010-12-31	-7,676,826	USD	365
2009-01-01 to 2009-12-31	-7,457,275	USD	365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2011-12-31	13,828,616	USD
At 2010-12-31	26,192,789	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2011-12-31	2,218,612	USD
At 2010-12-31	1,597,712	USD

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2011-12-31	54,565,358	shares
At 2010-12-31	54,116,628	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2011-12-31	62,167,748	USD
At 2010-12-31	59,577,974	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2011-12-31	329,244	USD
At 2010-12-31	642,392	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2011-01-01 to 2011-12-31	3,425,400	USD	365
2005-06-01 to 2011-12-31	17,101,969	USD	2405
2010-01-01 to 2010-12-31	2,457,043	USD	365
2009-01-01 to 2009-12-31	1,901,952	USD	365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2011-01-01 to 2011-12-31	174,027	USD	365
2005-06-01 to 2011-12-31	459,929	USD	2405
2010-01-01 to 2010-12-31	86,960	USD	365
2009-01-01 to 2009-12-31	78,509	USD	365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2005-06-01 to 2011-12-31	47,188,418	USD	2405
2010-01-01 to 2010-12-31	26,876,684	USD	365
2009-01-01 to 2009-12-31	2,000,000	USD	365

Inspect the source

Entity: PROLOR BIOTECH, INC. / CIK 0001268659
Captured: 2026-09-23 02:45 UTC
SEC response SHA-256: 01cb5b17f5964303e8d5f81436b176c05cd2969d236c4dc3312077bedcc722d4

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001268659.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))